Organon & Co

NYSE:OGNUnited States

Organon & Co. is a global health care company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions. Its portfolio also includes VTAMA (tapinarof) cream, 1%, a nonbiologic, non-steroidal topical therapy, for treatment of mild, moderate, and severe plaque psoriasis in adults.

Contact Information

Headquarters

30 Hudson Street, Fl 33JERSEY CITY, NJ, United States 07302

Phone

551-430-6000

Fax

302-655-5049

Executives

Independent Chairman of the Board

Carrie Cox

Chief Executive Officer, Director

Kevin Ali

Chief Financial Officer, Executive Vice President

Matthew Walsh

Chief Human Resource Officer, Executive Vice President

Aaron Falcione

Executive Vice President, Chief Information Officer

Rachel Stahler